Secondary Logo

Institutional members access full text with Ovid®

The Effect of Changing the Amyloid β42 Cut-off of Cerebrospinal Fluid Biomarkers on Alzheimer Disease Diagnosis in a Memory Clinic Population in Norway

Knapskog, Anne-Brita, MD, PhD*; Braekhus, Anne, MD, PhD*,†; Engedal, Knut, MD, PhD

Alzheimer Disease & Associated Disorders: January-March 2019 - Volume 33 - Issue 1 - p 72–74
doi: 10.1097/WAD.0000000000000268
Brief Reports
Buy

*Department of Geriatric Medicine, Oslo University Hospital, Ullevaal, Oslo

Norwegian National Advisory Unit on Ageing and Health, Vestfold Hospital Trust, Tønsberg, Norway

A.-B.K. receives funding from the Norwegian Health Association’s research program. The remaining authors declare no conflicts of interest.

Reprints: Anne-Brita Knapskog, MD, PhD, Department of Geriatric Medicine, Memory Clinic, Oslo University Hospital, Ullevaal, Postboks 4956, Nydalen, Oslo 0424, Norway (e-mail: anne-brita.knapskog@knapskog.net).

Received February 5, 2018

Accepted July 9, 2018

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved